CLINICAL_TRIALS
research
· 2012-09-06
Clinical Trial Update: Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal Cancer [Phase 2]
Summary
Phase 2 clinical trial evaluating bevacizumab in combination with chemotherapy for metastatic colorectal cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chinese Academy of Medical Sciences | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN